Search CDMOs

• AAV Manufacturing
• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development

UK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle.

• AAV Manufacturing
• CMC Analytical Development
• CMC Regulatory Submission Support

Dedicated AAV gene therapy CDMO with a 200,000+ sq. ft. cGMP facility featuring 20 suites and bioreactors up to 5,000L, supporting 60+ clients across 35+ indications with high-yield manufacturing and seamless regulatory compliance.

• AAV Manufacturing
• CMC Analytical Development
• Cell-Line Development

CDMO specializing in plasmid DNA and AAV viral vector manufacturing for cell and gene therapy, with digital-first platform emphasizing data integrity and collaboration.

• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development
• Biologics Development & Manufacturing

Swiss-based pure-play biologics CDMO specializing in next-generation bioprocessing technologies including process intensification and full perfusion to reduce cost of goods for biotech and biosimilar clients.

• CMC Analytical Development
• Biologics Development & Manufacturing
• Cell-Line Development

Global CDMO offering cell line development, process development, analytical services, and cGMP clinical and commercial manufacturing for biologics including monoclonal antibodies and recombinant proteins.

• AAV Manufacturing
• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development

Global CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Global CDMO with 30+ years of experience offering integrated services across small molecule, generic APIs, sterile drug product, and biologics manufacturing, backed by 20+ facilities and 3,000+ professionals across North America, Europe, and India.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Cartridge Filling

Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

North American CDMO specializing in clinical-to-commercial biologics, small molecules, HPAPIs, and bioreagents with 50+ years of microbial fermentation and complex chemistry expertise across cGMP facilities in Canada.

• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development
• Autologous Cell Therapy Manufacturing

End-to-end CDMO specializing in complex modalities including cell, gene, and RNA-based therapies with North American manufacturing facilities and development capabilities.

• CMC Analytical Development
• Biologics Development & Manufacturing
• Cell-Line Development

CDMO partner offering end-to-end biologics development and manufacturing from pre-clinical through commercialization, with expertise in cell culture, microbial fermentation, cell and gene therapy, and cGMP manufacturing across US and European facilities.

• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development
• Biologics Development & Manufacturing

Global biologic CDMO offering end-to-end solutions from discovery to commercialization.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.

• AAV Manufacturing
• CMC Analytical Development
• API Synthesis & Manufacturing

Leading global CDMO offering end-to-end development and manufacturing for pharma, biotech, and consumer health—spanning oral dose, biologics, cell and gene therapies, clinical supply, and specialty formulations with advanced technologies and worldwide GMP capacity.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Fully integrated biopharmaceutical company developing affordable biosimilars, generic formulations, and complex APIs for diabetes, cancer, and autoimmune diseases.

• Biologics Development & Manufacturing
• Downstream Processing
• Monoclonal Antibody (mAb) Manufacturing

CDMO and CRO offering downstream processing, protein purification, and manufacturing capabilities for therapeutic antibodies and biologics from discovery through commercialization.

• AAV Manufacturing
• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis

Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.

• AAV Manufacturing
• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis

Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.